The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 40 results:
Author Title [ Type(Desc)] Year
Filters: Author is Darwiche, Kaid  [Clear All Filters]
Journal Article
Zaric, B., Stojsic V., Tepavac A., Sarcev T., Zarogoulidis P., Darwiche K., et al. (2013).  Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC).. J Thorac Dis. 5 Suppl 4, S371-7.
Zaric, B., Stojsic V., Sarcev T., Stojanovic G., Carapic V., Perin B., et al. (2013).  Advanced bronchoscopic techniques in diagnosis and staging of lung cancer.. J Thorac Dis. 5 Suppl 4, S359-70.
Walter, R. F. H., Zarogoulidis P., Mairinger F. D., Werner R., Darwiche K., Zarogoulidis K., et al. (2014).  Cell viability of fibroblasts to pifenidone and sirolimus: a future concept for drug eluting stents.. Int J Pharm. 466(1-2), 38-43.
Hohenforst-Schmidt, W., Zarogoulidis P., Vogl T., J Turner F., Browning R., Linsmeier B., et al. (2014).  Cone Beam Computertomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime Navigation.. J Cancer. 5(3), 231-41.
Domvri, K., Bougiouklis D., Zarogoulidis P., Porpodis K., Xristoforidis M., Liaka A., et al. (2015).  Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?. J Cancer. 6(4), 360-6.
Hohenforst-Schmidt, W., Zarogoulidis P., Stopek J., Vogl T., Hübner F., J Turner F., et al. (2015).  DDMC-p53 gene therapy with or without cisplatin and microwave ablation.. Onco Targets Ther. 8, 1165-73.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Lampaki, S., Lazaridis G., Zarogoulidis K., Kioumis I., Papaiwannou A., Tsirgogianni K., et al. (2015).  Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer.. J Cancer. 6(6), 568-74.
Hohenforst-Schmidt, W., Zarogoulidis P., Oezkan F., Mahnkopf C., Grabenbauer G., Kreczy A., et al. (2014).  "Denervation" of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome.. Ther Clin Risk Manag. 10, 207-15.
Darwiche, K., Zarogoulidis P., Karamanos N. K., Domvri K., Chatzaki E., Constantinidis T. C., et al. (2013).  Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.. Future Oncol. 9(4), 505-25.
Milovancev, A., Stojsic V., Zaric B., Kovacevic T., Sarcev T., Perin B., et al. (2015).  EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?. Onco Targets Ther. 8, 2915-21.
Huang, H., Li C., Zarogoulidis P., Darwiche K., Machairiotis N., Yang L., et al. (2013).  Endometriosis of the lung: report of a case and literature review.. Eur J Med Res. 18, 13.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
Huang, H., Zarogoulidis P., Lampaki S., Organtzis J., Petridis D., Porpodis K., et al. (2014).  Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.. J Thorac Dis. 6(10), 1411-9.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.
Domvri, K., Darwiche K., Zarogoulidis P., & Zarogoulidis K. (2013).  Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapy.. Transl Lung Cancer Res. 2(4), 256-8.
Zarogoulidis, P., Petridis D., Ritzoulis C., Li Q., Huang H., Ning Y., et al. (2013).  Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.. Int J Pharm. 458(1), 39-47.
Zarogoulidis, K., Ziogas E., Boutsikou E., Zarogoulidis P., Darwiche K., Kontakiotis T., et al. (2013).  Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.. Drug Des Devel Ther. 7, 611-7.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Zarogoulidis, P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., et al. (2013).  Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.. Future Oncol. 9(8), 1171-94.
Zarogoulidis, P., Yarmus L., Darwiche K., Walter R., Huang H., Li Z., et al. (2013).  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.. Immunome Res. 9(62), 16535.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Kioumis I., Porpodis K., et al. (2013).  Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.. Int J Pharm. 456(2), 325-31.
Hohenforst-Schmidt, W., Zarogoulidis P., Darwiche K., Vogl T., Goldberg E. P., Huang H., et al. (2013).  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.. Drug Des Devel Ther. 7, 571-83.
Zarogoulidis, P., Darwiche K., Tsakiridis K., Teschler H., Yarmus L., Zarogoulidis K., et al. (2013).  Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.. J Mol Genet Med. 7, 65.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Tsakiridis K., Machairiotis N., Kougioumtzi I., et al. (2013).  Malignant pleural effusion and algorithm management.. J Thorac Dis. 5 Suppl 4, S413-9.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.